How the Practice/Academic Partnership Model Helped One State During COVID-19

During the spring and summer of 2020, boards of nursing (BONs) throughout the U.S. were faced with requests from educational programs for ways to replace clinical hours due to the inability to access clinical sites caused by the COVID-19 pandemic. While many clinical sites have since reopened to nursing students, some barriers still remain, resulting in a backlog of clinical hours for many nursing students throughout the state of Connecticut. Reflecting on lessons learned over the past year, collaboration between the BON and nursing leaders throughout the state has proved essential to providing the practice hours and clinical learning experiences needed to assure that students meet graduation goals and expectations for future clinical practice as an RN

Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study

Background: Fatigue is one of the most commonly reported subjective symptoms following traumatic brain injury (TBI). The aims were to assess frequency of fatigue over the first 6 months after TBI, and examine whether fatigue changes could be predicted by demographic characteristics, injury severity and comorbidities. Methods: Patients with acute TBI admitted to 65 trauma centers were enrolled in the study Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI). Subj

Learning words from written context: effect of emotional verbal context.

International audienc

Evaluation de la qualité de la prise en charge des patients atteints de la maladie d'alzheimer par les médecins généralistes de la Haute-Vienne

En 1901 Alois Alzheimer rencontra Auguste D., patiente à l origine de la description de la maladie d Alzheimer. En 2001, le gouvernement établit le premier plan destiné à améliorer la prise en charge des patients atteints de cette maladie. Celle-ci est érigée au rang de Grande Cause Nationale pour 2007. L objectif de ce travail est de déterminer les axes nécessitant un complément de formation pour les médecins généralistes de la Haute-Vienne confrontés à la maladie d Alzheimer. Nous leur avons fait parvenir un questionnaire afin d évaluer leurs connaissances et leurs pratiques et de repérer les obstacles à la prise en charge rencontrés au quotidien. Le taux de réponse au questionnaire fut de 36%. Les connaissances sur la maladie sont bonnes, mais l analyse des pratiques révèle des lacunes dans le dépistage, l usage des tests neuropsychologiques et les examens biologiques à réaliser. Les symptômes amenant à la consultation spécialisée sont ceux d une démence évoluée, indiquant un important retard diagnostic. Un médecin sur deux n initie pas le traitement spécifique au stade précoce de la maladie. Les principaux obstacles à la prise en charge relevés par les médecins sont le manque de plainte mnésique de la part du patient et le déni des familles. Les autres facteurs défavorables sont la longue durée de la consultation de dépistage et un sentiment d inefficacité du traitement médicamenteux. D après nos résultats, les FMC des médecins généralistes doivent porter sur l intérêt du dépistage et du traitement précoce de la maladie d Alzheimer. La population doit être sensibilisée aux symptômes d alerte de la maladie et il faut encourager la recherche d un traitement curatif.LIMOGES-BU Médecine pharmacie (870852108) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Evaluation de la qualité de la prise en charge des patients atteints de la maladie d'alzheimer par les médecins généralistes de la Haute-Vienne

En 1901 Alois Alzheimer rencontra Auguste D., patiente à l origine de la description de la maladie d Alzheimer. En 2001, le gouvernement établit le premier plan destiné à améliorer la prise en charge des patients atteints de cette maladie. Celle-ci est érigée au rang de Grande Cause Nationale pour 2007. L objectif de ce travail est de déterminer les axes nécessitant un complément de formation pour les médecins généralistes de la Haute-Vienne confrontés à la maladie d Alzheimer. Nous leur avons fait parvenir un questionnaire afin d évaluer leurs connaissances et leurs pratiques et de repérer les obstacles à la prise en charge rencontrés au quotidien. Le taux de réponse au questionnaire fut de 36%. Les connaissances sur la maladie sont bonnes, mais l analyse des pratiques révèle des lacunes dans le dépistage, l usage des tests neuropsychologiques et les examens biologiques à réaliser. Les symptômes amenant à la consultation spécialisée sont ceux d une démence évoluée, indiquant un important retard diagnostic. Un médecin sur deux n initie pas le traitement spécifique au stade précoce de la maladie. Les principaux obstacles à la prise en charge relevés par les médecins sont le manque de plainte mnésique de la part du patient et le déni des familles. Les autres facteurs défavorables sont la longue durée de la consultation de dépistage et un sentiment d inefficacité du traitement médicamenteux. D après nos résultats, les FMC des médecins généralistes doivent porter sur l intérêt du dépistage et du traitement précoce de la maladie d Alzheimer. La population doit être sensibilisée aux symptômes d alerte de la maladie et il faut encourager la recherche d un traitement curatif.LIMOGES-BU Médecine pharmacie (870852108) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Tell Me about Regret: Studying Regret Inferences from Written Stories in Adults and Children

International audienceEmotional development relies on the development of emotional concepts and emotion labels. We examined 3rd-5th grade children’s ability to label and identify regret and disappointment – i.e., choosing an emotional label or reporting an emotional intensity among a pre-established list of emotions. Sixty-one 3rd-grade children, 63 4th-grade children, 71 5th-grade children and 80 adults (18-30 years) read short stories (116 words on average) designed to elicit sadness, anger, shame, guilt, disappointment and regret. We assessed emotion labeling by asking participants to label the emotions felt after each story, and we assessed emotional identification through the reporting of the intensity with which they felt listed emotions. Children identified disappointment at 8-9 years, and regret at 10-11 years. However, regret and disappointment labeling remained rare at 10-11 years. Our results indicate that the identification of these emotions precedes their labeling and show a developmental increase in regret and disappointment recognition from 3rd to 5th grade

Tell Me about Regret: Studying Regret Inferences from Written Stories in Adults and Children

International audienceEmotional development relies on the development of emotional concepts and emotion labels. We examined 3rd-5th grade children’s ability to label and identify regret and disappointment – i.e., choosing an emotional label or reporting an emotional intensity among a pre-established list of emotions. Sixty-one 3rd-grade children, 63 4th-grade children, 71 5th-grade children and 80 adults (18-30 years) read short stories (116 words on average) designed to elicit sadness, anger, shame, guilt, disappointment and regret. We assessed emotion labeling by asking participants to label the emotions felt after each story, and we assessed emotional identification through the reporting of the intensity with which they felt listed emotions. Children identified disappointment at 8-9 years, and regret at 10-11 years. However, regret and disappointment labeling remained rare at 10-11 years. Our results indicate that the identification of these emotions precedes their labeling and show a developmental increase in regret and disappointment recognition from 3rd to 5th grade

Centering inclusivity in the design of online conferences - An OHBM - Open Science perspective

As the global health crisis unfolded throughout the world, many academic conferences moved online in 2020. This move has been hailed as a positive step towards inclusivity in its attenuation of economic, physical and legal barriers and effectively enabled many individuals who have traditionally been underrepresented to join and participate. A number of studies have outlined how moving online made it possible to gather a more global community and has increased opportunities for individuals with various constraints, e.g. caregiving responsibilities. Yet, the mere existence of online conferences is unfortunately no guarantee that everyone can attend and participate meaningfully. In fact, many elements of an online conference are still significant barriers to truly diverse participation: the tools used can be inaccessible for some individuals; the scheduling choices can favour some geographical locations; the setup of the conference can provide more visibility to well-established researchers and reduce opportunities for early career researchers. While acknowledging the benefits of an online setting, especially for individuals who have traditionally been underrepresented or excluded, we recognize that fostering social justice requires inclusivity to actively be centered in every aspect of online conference design. Here, we draw from the literature and from our own experiences to identify practices that purposefully encourage a diverse community to: attend, participate in, and lead online conferences. Reflecting on how to design more inclusive online events is especially important as multiple scientific organizations have announced that they will continue offering an online version of their event when in-person conferences can resume

Rehabilitation and outcomes after complicated vs uncomplicated mild TBI: results from the CENTER-TBI study

International audienceBackground: Despite existing guidelines for managing mild traumatic brain injury (mTBI), evidence-based treatments are still scarce and large-scale studies on the provision and impact of specific rehabilitation services are needed. This study aimed to describe the provision of rehabilitation to patients after complicated and uncomplicated mTBI and investigate factors associated with functional outcome, symptom burden, and TBI-specific health-related quality of life (HRQOL) up to six months after injury. Methods: Patients (n = 1379) with mTBI from the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study who reported whether they received rehabilitation services during the first six months post-injury and who participated in outcome assessments were included. Functional outcome was measured with the Glasgow Outcome Scale – Extended (GOSE), symptom burden with the Rivermead Post Concussion Symptoms Questionnaire (RPQ), and HRQOL with the Quality of Life after Brain Injury – Overall Scale (QOLIBRI-OS). We examined whether transition of care (TOC) pathways, receiving rehabilitation services, sociodemographic (incl. geographic), premorbid, and injury-related factors were associated with outcomes using regression models. For easy comparison, we estimated ordinal regression models for all outcomes where the scores were classified based on quantiles. Results: Overall, 43% of patients with complicated and 20% with uncomplicated mTBI reported receiving rehabilitation services, primarily in physical and cognitive domains. Patients with complicated mTBI had lower functional level, higher symptom burden, and lower HRQOL compared to uncomplicated mTBI. Rehabilitation services at three or six months and a higher number of TOC were associated with unfavorable outcomes in all models, in addition to pre-morbid psychiatric problems. Being male and having more than 13 years of education was associated with more favorable outcomes. Sustaining major trauma was associated with unfavorable GOSE outcome, whereas living in Southern and Eastern European regions was associated with lower HRQOL. Conclusions: Patients with complicated mTBI reported more unfavorable outcomes and received rehabilitation services more frequently. Receiving rehabilitation services and higher number of care transitions were indicators of injury severity and associated with unfavorable outcomes. The findings should be interpreted carefully and validated in future studies as we applied a novel analytic approach. Trial registration: ClinicalTrials.gov NCT02210221